LINC01410 and cholangiocarcinoma: Studies on cholangiocarcinoma (CCA) have demonstrated that LINC01410 acts as a sponge for miR-124-3p, upregulating SMAD5, thereby promoting the proliferation, invasion, and migration of CCA cells and tissues (24).